Page 370 - HIVMED_v21_i1.indb

Page 8 of 8 Original Research

17. Menon S, Wusiman A, Boily MC, et al. Epidemiology of HPV genotypes among HIV 28. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human
positive women in Kenya: A systematic review and meta-analysis. PLoS One. papillomavirus types in cytologically normal women in the International Agency
2016;11(10):e0163965. https://doi.org/10.1371/journal.pone.0163965 for Research on Cancer HPV prevalence surveys: A pooled analysis. Lancet. 2005
18. Ezechi OC, Ostergren PO, Nwaokorie FO, Ujah IAO, Odberg Pettersson K. The Sep 17;366(9490):991–998. https://doi.org/10.1016/s0140-6736(05)67069-9
burden, distribution and risk factors for cervical oncogenic human papilloma virus 29. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, et al. Prevalence and
infection in HIV positive Nigerian women. Virol J. 2014 Jan 15;11:5. https://doi. predictors of squamous intraepithelial lesions of the cervix in HIV-infected women
org/10.1186/1743-422x-11-5 in Lusaka, Zambia. Gynecol Oncol. 2006;103(3):1017–1022. https://doi.org/
19. Reddy D, Njala J, Stocker P, et al. High-risk human papillomavirus in HIV- 10.1016/j.ygyno.2006.06.015
infected women undergoing cervical cancer screening in Lilongwe, Malawi: A 30. Akarolo-Anthony SN, Al-Mujtaba M, Famooto AO, et al. HIV associated high-risk
pilot study. Int J STD AIDS. 2015;26(6):379–387. https://doi.org/10.1177/0956 HPV infection among Nigerian women. BMC Infect Dis. 2013 Nov 05;13:521.
462414539149 https://doi.org/10.1186/1471-2334-13-521
20. Firnhaber C, Van Le H, Pettifor A, et al. Association between cervical dysplasia and 31. Demarco M, Hyun N, Carter-Pokras O, et al. A study of type-specific HPV natural
human papillomavirus in HIV seropositive women from Johannesburg South history and implications for contemporary cervical cancer screening programs.
Africa. Cancer Causes Control. 2010 Mar 01;21(3):433–443. https://doi. EClinicalMedicine. 2020;22:100293. https://doi.org/10.1016/j.eclinm.2020.100293
org/10.1007/s10552-009-9475-z 32. amFAR, The Foundation for AIDS Research (November, 2016) Cervical cancer,
21. Fukuchi E, Sawaya GF, Chirenje M, et al. Cervical human papillomavirus Human papillomavirus (HPV), and HPV vaccines in Southeast Asia [homepage on
incidence and persistence in a cohort of HIV-negative women in Zimbabwe. Sex the Internet]. 2016 [cited 2020 May 01]. Available from: www.amfar.org
Transm Dis. 2009 May;36(5):305–311. https://doi.org/10.1097/OLQ.0b013e31 33. Van Der Weele P, Breeuwsma M, Donken R, et al. Effect of the bivalent HPV
8194eb76 vaccine on viral load of vaccine and non-vaccine HPV types in incident clearing
22. Macleod IJ, O’donnell B, Moyo S, et al. Prevalence of human papillomavirus and persistent infections in young Dutch females. PLoS One. 2019 Mar
genotypes and associated cervical squamous intraepithelial lesions in HIV- 01;14(3):e0212927. https://doi.org/10.1371/journal.pone.0212927
infected women in Botswana. J Med Virol. 2011;83(10):1689–1695. https://doi. 34. Richter K, Becker P, Horton A, Dreyer G. Age-specific prevalence of cervical human
org/10.1002/jmv.22178 papillomavirus infection and cytological abnormalities in women in Gauteng
23. Shamu T, Chimbetete C, Shawarira–Bote S, Mudzviti T, Luthy R. Outcomes of an Province. S Afr Med J [serial online]. 2013 Mar 01;103(5):313. https://doi.
HIV cohort after a decade of comprehensive care at Newlands Clinic in Harare, org/10.7196/SAMJ.6514
Zimbabwe: TENART cohort. PLoS One [serial online]. 2017 Oct 24 [cited 2018 35. Van Aardt MC, Dreyer G, Richter KL, Becker P. Human papillomavirus-type
Dec 12];12(10):e0186726. Available from: https://doi.org/10.1371/journal.pone. distribution in South African women without cytological abnormalities: A peri-
0186726 urban study. S Afr J Gynaecol Oncol [serial online]. 2013 Jan 15;5(Suppl 1):
24. Akbari A, Vanden Broeck D, Benoy I, Padalko E, Bogers J, Arbyn M. Validation of S21–S27. https://doi.org/10.1080/20742835.2013.11441218
intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the 36. Auwal I, Aminu M, Atanda A, Tukur J, Sarkinfada F. Prevalence and risk factors of
international guidelines for cervical cancer screening. Virol J. 2018 Oct high risk human papillomavirus infections among women attending gynaecology
29;15(1):166. https://doi.org/10.1186/s12985-018-1076-6 clinics in Kano, Northern Nigeria. Bayero J Pure Appl Sci. 2014 Jan 07;6(1):67.
25. Ndizeye Z, Broeck DV, Lebelo RL, et al. Prevalence and genotype-specific https://doi.org/10.4314/bajopas.v6i1.14
distribution of human papillomavirus in Burundi according to HIV status and 37. Akarolo-Anthony SN, Famooto AO, Dareng EO, et al. Age-specific prevalence of
urban or rural residence and its implications for control. PLoS One [serial online]. human papilloma virus infection among Nigerian women. BMC Public Health.
2019 [cited 2020 Mar 25];14(6):e0209303. Available from: https://doi. 2014 Jun 27;14:656. https://doi.org/10.1186/1471-2458-14-656
org/10.1371/journal.pone.0209303
38. Menon S, Rossi R, Zdraveska N, et al. Associations between highly active
26. Menon SS, Rossi R, Harebottle R, Mabeya H, Vanden Broeck D. Distribution of antiretroviral therapy and the presence of HPV, premalignant and malignant
human papillomaviruses and bacterial vaginosis in HIV positive women with cervical lesions in sub-Saharan Africa: A systematic review: Current evidence and
abnormal cytology in Mombasa, Kenya. Infect Agent Cancer. 2016;11:17. https:// directions for future research. BMJ Open. 2017 Aug 04;7(8):e015123. https://doi.
doi.org/10.1186/s13027-016-0061-1 org/10.1136/bmjopen-2016-015123
27. Clifford GM, Tully S, Franceschi S. Carcinogenicity of human papillomavirus (HPV) 39. Schiffman M, Glass AG, Wentzensen N, et al. A long-term prospective study of
types in HIV-positive women: A meta-analysis from HPV infection to cervical type-specific human papillomavirus infection and risk of cervical neoplasia among
cancer. Clin Infect Dis. 2017 May 01;64(9):1228–1235. https://doi.org/10.1093/ 20,000 women in the Portland Kaiser cohort study. Cancer Epidemiol Biomarkers
cid/cix135 Prev. 2011;20(7):1398–1409. https://doi.org/10.1158/1055-9965.EPI-11-0206

http://www.sajhivmed.org.za 362 Open Access